Preliminary results from TRITON2: A phase II study of rucaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination repair (HRR) gene alterations.
暂无分享，去创建一个
H. Scher | A. Bryce | A. Patnaik | W. Abida | Jingsong Zhang | A. Patnaik | R. Amato | N. Vogelzang | A. Hussain | S. Chowdhury | C. Ryan | R. McDermott | C. Ryan | J. Zhang | D. Despain | I. Percent | D. Petrylak | A. Simmons | J. Shapiro | T. Golsorkhi | T. Stanton | A. Hussain | M. Collins | T. Golsorskhi | Jeremy B. Shapiro